Phase II trial of roxadustat for chemotherapy-induced anemia meets primary efficacy endpoint Aug. 25, 2021
Ascletis completes bridging study and opens Chinese phase II trial of ASC-42 for chronic hepatitis B Aug. 25, 2021
Stachydrine-leonurine conjugate SL-06 ameliorates experimental cerebral ischemic stroke Aug. 25, 2021
Bio-Path receives IND clearance for phase I/Ib study of BP-1002 in relapsed or refractory AML Aug. 25, 2021
RSS